INFUSYSTEM HOLDINGS, INC Lease Obligation Incurred
INFUSYSTEM HOLDINGS, INC (INFU) reported Lease Obligation Incurred of $137.00 thousand for the 12-month period ending 2017-12-31, per its 10-K filed 2019-03-22.
Discontinued › Cash Flow › Other Cash Flow Items
us-gaap:CapitalLeaseObligationsIncurred · last filed 2019-03-22
- INFUSYSTEM HOLDINGS, INC lease obligation incurred for the quarter ending 2012-12-31 was $0.00.
- INFUSYSTEM HOLDINGS, INC lease obligation incurred for the quarter ending 2012-09-30 was $65.00K, a 80.48% decline year-over-year.
- INFUSYSTEM HOLDINGS, INC lease obligation incurred for the quarter ending 2012-06-30 was $153.00K, a 88.61% decline year-over-year.
- INFUSYSTEM HOLDINGS, INC lease obligation incurred for the quarter ending 2012-03-31 was $304.00K, a 51.28% decline year-over-year.
- INFUSYSTEM HOLDINGS, INC lease obligation incurred for fiscal 2017 was $137.00K, a 94.88% decline from fiscal 2016.
- INFUSYSTEM HOLDINGS, INC lease obligation incurred for fiscal 2016 was $2.67M, a 36.81% decline from fiscal 2015.
- INFUSYSTEM HOLDINGS, INC lease obligation incurred for fiscal 2015 was $4.23M, a 17.71% increase from fiscal 2014.
- INFUSYSTEM HOLDINGS, INC lease obligation incurred for fiscal 2014 was $3.60M, a 41.52% increase from fiscal 2013.
| Period end | Lease Obligation Incurred 3 month | Lease Obligation Incurred 6 month | Lease Obligation Incurred 9 month | Lease Obligation Incurred 12 month |
|---|---|---|---|---|
| 2017-12-31 | $137.00K 10-K · filed 2019-03-22 | |||
| 2016-12-31 | $2.67M 10-K · filed 2018-03-19 | |||
| 2015-12-31 | $4.23M 10-K · filed 2017-03-22 | |||
| 2014-12-31 | $3.60M 10-K/A · filed 2016-12-12 | |||
| 2013-12-31 | $2.54M 10-K · filed 2015-03-09 | |||
| 2012-12-31 | $0.00 derived: 10-K 12 month − 10-Q 9 month · filed 2014-03-11 | $65.00K derived: sum of 2 quarters · filed 2014-03-11 | $218.00K derived: sum of 3 quarters · filed 2014-03-11 | $522.00K 10-K · filed 2014-03-11 |
| 2012-09-30 | $65.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2012-11-14 | $218.00K derived: sum of 2 quarters · filed 2012-11-14 | $522.00K 10-Q · filed 2012-11-14 | $522.00K derived: sum of 4 quarters · filed 2013-03-28 |
| 2012-06-30 | $153.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2012-08-08 | $457.00K 10-Q · filed 2012-08-08 | $457.00K derived: sum of 3 quarters · filed 2013-03-28 | $790.00K derived: sum of 4 quarters · filed 2013-03-28 |
| 2012-03-31 | $304.00K 10-Q · filed 2012-05-21 | $304.00K derived: sum of 2 quarters · filed 2013-03-28 | $637.00K derived: sum of 3 quarters · filed 2013-03-28 | $1.98M derived: sum of 4 quarters · filed 2013-03-28 |
| 2011-12-31 | $0.00 derived: 10-K 12 month − 10-Q 9 month · filed 2013-03-28 | $333.00K derived: sum of 2 quarters · filed 2013-03-28 | $1.68M derived: sum of 3 quarters · filed 2013-03-28 | $2.30M 10-K · filed 2013-03-28 |
| 2011-09-30 | $333.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2012-11-14 | $1.68M derived: sum of 2 quarters · filed 2012-11-14 | $2.30M 10-Q · filed 2012-11-14 | $2.30M derived: sum of 4 quarters · filed 2012-11-14 |
| 2011-06-30 | $1.34M derived: 10-Q 6 month − 10-Q 3 month · filed 2012-08-08 | $1.97M 10-Q · filed 2012-08-08 | $1.97M derived: sum of 3 quarters · filed 2012-08-08 | $2.46M derived: sum of 4 quarters · filed 2012-08-08 |
| 2011-03-31 | $624.00K 10-Q · filed 2012-05-21 | $624.00K derived: sum of 2 quarters · filed 2012-05-21 | $1.12M derived: sum of 3 quarters · filed 2012-05-21 | |
| 2010-12-31 | $0.00 derived: 10-K 12 month − 10-Q 9 month · filed 2012-03-16 | $497.00K derived: sum of 2 quarters · filed 2012-03-16 | $1.87M 10-K · filed 2012-03-16 | |
| 2010-09-30 | $497.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2011-11-14 | $1.87M 10-Q · filed 2011-11-14 | ||
| 2010-06-30 | $1.37M 10-Q · filed 2011-08-15 | |||
| 2009-12-31 | $2.20M 10-K · filed 2012-03-16 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| UTAH MEDICAL PRODUCTS INC (UTMD) | United States | $0.238B | 20.93 |
| Anika Therapeutics, Inc. (ANIK) | United States | $0.272B | -51.71 |
| ORASURE TECHNOLOGIES INC (OSUR) | United States | $0.272B | -6.26 |
| PRO DEX INC (PDEX) | United States | $0.234B | 13.64 |
| Cytosorbents Corp (CTSO) | United States | $0.274B | -1.29 |
| TriSalus Life Sciences, Inc. (TLSI) | United States | $0.283B | -9.92 |
| Neuronetics, Inc. (STIM) | United States | $0.216B | -3.25 |
| Mobia Medical, Inc. (MOBI) | United States | $0.293B | |
| TREACE MEDICAL CONCEPTS, INC. (TMCI) | United States | $0.297B | -4.32 |
| Profound Medical Corp. (PROF) | $0.206B | -7.37 |